Tags : Schrödinger

Weekly Snapshot

PharmaShots Weekly Snapshot (Nov 23 – 27, 2020)

Merck Collaborates with Siemens for the Digitalization of Production Published: Nov 26, 2020 | Tags: Agreement, Collaborative, Digitalization, Merck, Siemens, Sign CoSara Receives CDSCO’s Approval for its Saragene COVID-19 2-Gene Multiplex Test Published: Nov 26, 2020 | Tags: approval, CDSCO, Co-Diagnostics JV CoSara, COVID-19 2-gene multiplex RT-PCR, India, Manufacture, receives, Saragene, Sell, Test PostEra Collaborates […]Read More


Schrödinger Signs a $2.7B Agreement with BMS to Develop and

Shots: Schrödinger to receive $55M upfront and is eligible to receive $2.7B as preclinical, development, regulatory & commercial milestones along with royalties on sales of each product commercialized by BMS Schrödinger to grant BMS exclusive WW rights to develop & commercialize the development candidates emerges from the collaboration The collaboration will merge Schrödinger’s computational platform […]Read More

COVID-19 MedTech

Schrodinger Expands its Drug Discovery Efforts Against COVID-19 Deploying Parallel

Shots: Schrodinger expands its work to discover novel antiviral therapies for COVID-19 as a part of a philanthropic global initiative. The accelerated pace includes the evaluation of billions of molecules/ week and is supported by Google Cloud which provides its high-powered parallel computing enabling the rapid exploration of chemical space Schrodinger has evaluated four different […]Read More


AstraZeneca Collaborates with Schrödinger to Utilize its Molecule-Modeling Platform for

Shots: AstraZeneca enters into an agreement with Schrödinger to deploy Schrödinger’s advanced computing platform for accelerating its drug discovery efforts AstraZeneca will utilize predictive physics-based modeling and machine learning platform to identify new therapies including an improvement in the design of its compounds  Schrödinger’s platform predicts the potency of a molecule binding to a target […]Read More